Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
Masahide Enomoto, Kosuke Kaji, Norihisa Nishimura, Yuki Fujimoto, Kōji Murata, Soichi Takeda, Yuki Tsuji, Yukihisa Fujinaga, Hiroaki Takaya, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Topics & Concepts
RifaximinLubiprostoneSteatohepatitisMedicineInternal medicineSmall intestinal bacterial overgrowthFibrosisBile acidEndocrinologyPharmacologyFatty liverIrritable bowel syndromeBiochemistryChemistryConstipationAntibioticsDiseaseChronic constipationGut microbiota and healthLiver Disease Diagnosis and TreatmentBarrier Structure and Function Studies